Breaking News, Collaborations & Alliances

RoslinCT and Lykan Bioscience Combine to Create Cell Therapy CDMO

Creates global leader in process development and GMP manufacturing of advanced cell and gene therapies with transatlantic footprint in the US and UK.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

RoslinCT, a cell and gene therapy contract development and manufacturing organization (CDMO) developing life-changing therapies in Edinburgh’s BioQuarter, and Lykan Bioscience, a CDMO focused on cell-based therapies, have entered into a business combination agreement to form a global advanced therapies CDMO. The combined group will offer process development expertise and cGMP manufacturing for a broad range of autologous and allogeneic cell therapies, with expertise in gene editing and indust...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters